UK INVESTIGATION OF DRUG BRIBES
The UK parliament is to begin a national level investigation into the alleged bribery of doctors by pharmaceutical sales reps. The allegations surfaced earlier in November when the Sunday Times revealed that Fisons' sales reps had offered money and inducements to doctors to prescribe the company's products (Marketletter November 22).
Fisons has confirmed that it had dismissed one employee and reprimanded another over improper sales practices. Also, says its chairman Cedric Scroggs in the Sunday Times, company investigations had showed that some doctors had been offered inducements. Glaxo has also been implicated in the scandal and has reported that it has sacked five of its sales staff for offering inducements.
The Commons select committee on health has decided to call on evidence from David Thomas, a former Fisons sales representative, as part of its investigations.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze